CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-04 | BENZENO SHARON Chief Business Development Off | Option exercise · Stock Option (Right to Buy) | −2,604 | 39,063 | ||
| 2020-08-04 | BENZENO SHARON Chief Business Development Off | Option exercise · Stock Option (Right to Buy) | −2,604 | 67,709 | ||
| 2020-08-04 | BENZENO SHARON Chief Business Development Off | Option exercise · Common Stock (Right to Buy) | −1,562 | 45,313 | ||
| 2020-08-04 | BENZENO SHARON Chief Business Development Off | Option exercise · Common Stock | −417 | 0 | ||
| 2020-08-03 | HILL NANCY LOUISE EVP, Operations & Program Mana | Option exercise | +1,600 | $0.84 | $1K | 11,600 |
| 2020-08-03 | HILL NANCY LOUISE EVP, Operations & Program Mana | Sale | −1,600 | $37.37 | $60K | 10,000 |
| 2020-08-03 | HILL NANCY LOUISE EVP, Operations & Program Mana | Option exercise · Stock Option (Right to Buy) | −1,600 | 99,000 | ||
| 2020-07-31 | ROBINS CHAD M CEO and Chairman | Option exercise | +16,680 | $0.33 | $6K | 1,794,860 |
| 2020-07-31 | ROBINS CHAD M CEO and Chairman | Sale | −15,480 | $37.19 | $576K | 1,779,380 |
| 2020-07-31 | ROBINS CHAD M CEO and Chairman | Sale | −1,200 | $37.79 | $45K | 1,778,180 |
| 2020-07-31 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −16,680 | 294,720 | ||
| 2020-07-30 | ROBINS CHAD M CEO and Chairman | Option exercise | +16,680 | $0.33 | $6K | 1,794,860 |
| 2020-07-30 | ROBINS CHAD M CEO and Chairman | Sale | −6,796 | $37.48 | $255K | 1,788,064 |
| 2020-07-30 | ROBINS CHAD M CEO and Chairman | Sale | −9,884 | $37.96 | $375K | 1,778,180 |
| 2020-07-30 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −16,680 | 311,400 | ||
| 2020-07-29 | ROBINS CHAD M CEO and Chairman | Option exercise | +20,668 | $0.33 | $7K | 1,798,848 |
| 2020-07-29 | ROBINS CHAD M CEO and Chairman | Sale | −20,668 | $38.14 | $788K | 1,778,180 |
| 2020-07-29 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −20,668 | 328,080 | ||
| 2020-07-24 | Taylor Stacy L SVP and General Counsel | Option exercise | +1,109 | $7.80 | $9K | 2,409 |
| 2020-07-24 | Taylor Stacy L SVP and General Counsel | Option exercise | +1,771 | $6.55 | $12K | 4,180 |
Page 96 of 120 · 2,386 trades